chetomin has been researched along with Triple Negative Breast Neoplasms in 1 studies
chetomin: C31H30N6O6S4, similar to epipolythiodioxopiperazines
chetomin : An organic heteropentacyclic compound of the class of epipolythiodioxopiperazine. Isolated from Chaetomium globosum and Farrowia seminuda, it exhibits immunosuppressive activity.
Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dewangan, J | 1 |
Srivastava, S | 1 |
Mishra, S | 1 |
Pandey, PK | 1 |
Divakar, A | 1 |
Rath, SK | 1 |
1 other study available for chetomin and Triple Negative Breast Neoplasms
Article | Year |
---|---|
Chetomin induces apoptosis in human triple-negative breast cancer cells by promoting calcium overload and mitochondrial dysfunction.
Topics: Antineoplastic Agents; Apoptosis; Calcium; Cell Line, Tumor; Disulfides; Dose-Response Relationship, | 2018 |